summari morn report reflect
progress compani turnaround effort still earli
turnaround encourag sequenti improv
zbh organ day-adjust growth profil y/i
rel notabl growth
acceler stack two-year basi beat
consensu expect top- bottom-lin made
chang full year outlook impli
de-risk underli basi fx increment
headwind weigh report result look
expect underli revenu growth rang
gross margin pressur y/i
due higher-cost inventori flow modest
improv oper margin expect driven
improv sale consist zbh prior commun
expect de-lever modestli lower effect tax rate
drive ep growth next year in-lin
consensu expect maintain
base approxim ep estim pleas
see note date novemb result reflect
sequenti improv outlook intact detail look
quarter
revis estim larg reflect higher fx
result adjust estim lower
revenu estim underli
underli reflect
higher fx year assum fx
headwind upper end compani
outlook headwind
lower ep penni report
maintain ep report
continu page
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
compani data secur llc estim reuter
ep exclud amort non-recur item
compani data secur llc estim reuter
continu previou page
result reflect sequenti improv deliv sale
y/i report y/i ex-fx y/i day-adjust estim
consensu manag look deliv growth weight averag market
growth wamgr underli basi begin deliv quarter
sell day estim benefit quarter slightli higher contribut
versu intern market segment hip drove beat rel estim follow
sport extrem trauma set dental knee well spine
craniomaxillofaci cmf larg in-lin sale came
deliv adjust ep y/i came estim
consensu result driven better-than-expect expens manag lower
effect tax rate off-set miss gross margin net-net good quarter
underli top-lin growth y/i growth ep
knee franchis focu got offenc rosa persona famili
product pleas note growth rate y/i ex-fx adjust sell day
impact knee sale versu compar estim
saw strong uptak across geographi acceler asiapacif
europ middl east africa emea america knee price improv sequenti
versu volum also healthi versu like due
extra sell day manag note major chang underli fundament knee
continu expect market growth rang neg price said
make progress drive long-term contract drive mix shift higher price item zbh
overal knee busi improv sequenti stack two-year basi got offenc
rosa tka total knee arthroplasti applic persona famili knee estim
place rosa system quarter estim system sin manag
expect continu sequenti improv placement expect place system
current estim system estim
zbh us knee growth ex-rosa declin low-singl digit versu flattish like due
greater focu rosa placement quarter look would expect launch
persona revis help underli growth full year benefit persona famili knee
hip drove beat rel estim pleas note growth rate y/i ex-fx adjust
sell day impact hip sale versu compar
estim result driven acceler emea
asiapacif america hip price also improv sequenti versu
volum versu like due extra sell day
recent launch avenir complet hip featur short stem anterior approach
contribut modestli quarter look ahead believ devic could drive faster growth
within franchis anterior approach use two-third hip surgeri faster
growth segment hip market also contempl mako hip provid timelin
bryan hanson note call short stem could drive busi market growth near-
term combin rosa hip could potenti drive busi market growth
much focu set franchis especi extrem sport medicin extrem
trauma set sale versu compar estim
set price wors sequenti versu volum improv
versu continu improv execut segment
challeng past benefit improv suppli level identifi set area
would like doubl given high-growth market result chang
competit dynam marketplac focus build special expect benefit
market-rel disrupt syk/wmgi acquisit near-term bryan hanson also note
area would consid tuck-in acquisit
spine dental perform continu improv underli basi spine cmf sale
versu compar estim price
versu volum versu zbh result continu
impact sale forc integr dis-synergi spine work
make progress off-set benefit uptak cmf thorac product dental sale
versu compar estim price improv
sequenti versu volum versu
franchis make progress work new market strategi portfolio realign sale
reorgan certain geographi also recent announc distribut agreement
benefit segment go forward overal franchis make progress
price target nc
price target base approxim cash ep estim risk
thesi includ increas invest slower procedur volum growth price pressur disrupt
integr biomet
zimmer biomet share trade roughli discount large-cap med-tech peer group believ
discount narrow compani benefit leadership new commercially-driven
ceo bryan hanson oper issu resolv pipelin begin fulli
warsaw indiana-bas zimmer biomet hold one world largest orthoped implant
manufactur compani global market leader billion reconstruct orthoped
implant busi hip knee implant togeth account roughli revenu
compani report sale billion
fiscal year end decemb cost good gross sell gener adminstr research total oper oper incom interest expens incom incom incom tax provis net incom minor net adjust dilut share adjust ep excl gener adminstr oper incom ebitda excl gener adminstr oper incom restat effect relat revenu custom contract present net period pension postretir benefit cost sourc compani report factset secur llc estim medic technolog
